Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4531-4536

  Su, Xiang Yu ^a   Yin, Hai Tao ^a   Li, Su Yi ^a   Huang, Xin En ^b   Tan, Hua Yang ^c   Dai, Hong Yu ^d   Shi, Fang Fang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Department of Chemotherapy   (China)

^c YIXING PEOPLE S HOSPITAL   (China)

^d NANJING CHEST HOSPITAL   (China)

Author keywords

Carcinoma; Cervix; Esophagus; Median effect principle; Nedaplatin cispaltin combined treatment; Ovaries

Indexed keywords

EID: 84874009133     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4531     Document Type: Article

References (18)

1. Adachi S, Ogasawara T, Wakimoto E et al (2001). Phase I/II study of intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical carcinoma. Cancer, 91, 74-9.
2. Brabec V, Kasparkova J (2002). Molecular aspects of resistance to antitumor platinum drugs. Drug Resist Update, 5, 147-61.
3. Chou TC (2007). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev, 59, 621-81.
4. Kim R, Minami K, Nishimoto N, et al (2001). Enhancement of antitumor effect by ntratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. Int J Oncol, 18, 363-7.
5. Koshiyama M, Kinezaki M, Uchida T, Sumitomo M (2005). Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin. Anticancer Res, 25, 4499-502.
6. Kunihiko K, Shoji K, Toshihiko T, et al(1995). In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under the c/t curve. J Cancer Res Clin Oncol, 121, 715-20.
7. Li S, Wang L, Lin Y, et al (2008). Reduction Nedaplatin combined with cisplatin as first-line therapy treat advanced esophageal carcinoma. Tumour, 28, 446-9.
8. Liu W, Li S, Huang X, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14.
9. Nial JW, Shonagh W, Gemma E, et al (2010). The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans, 39, 8113-27.
10. Nishida M, Satoh Y, Nishide K, et al (1999). Phase I study of a combination chemotherapy of nedaplatin and cisplatin. Gan To Kagaku Ryoho, 26, 2209-15.
11. Pasetto LM, D'Andrea MR, Brandes AA, et al (2006). The development of platinum compounds and their possible combination. Crit Rev Oncol Hematol, 60, 59-75.
12. Risa T, Yasushi T, Yoshihiro S, et al (2005). In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Cancer Chemother Pharmacol, 56, 279-85.
13. Taguchi T, Wakui A, Nabeya K, et al (1992). A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. Jpn J Cancer Chemother, 19, 483-8.
14. Takeuchi H, Ozawa S, Ando N, et al (2003). Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol, 10, 792-800.
15. Takeki U, Jyoji Y, Mikinori T, et al (2011). Comparative nephrotoxicity of cisplatin and nedaplatin:mechanisms and histopathological characteristics. Toxicol Pathol, 24, 87-94.
16. Tanaka R, Takii Y, Shibata Y, et al (2005). In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Cancer Chemother Pharmacol, 56, 279-85.
17. Uehara T, Watanabe, Itoh F, et al (2005). Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch Toxicol, 79, 451-60.
18. Yao X, Panichpisal K, Kurtzman N, et al (2007). Cisplatin nephrotoxicity: a review. Am J Med Sci, 334, 115-24